Capricorn Partners

Capricorn Partners is an independent venture capital firm based in Leuven, Belgium, founded in 1993. The firm specializes in managing pan-European venture capital funds, focusing on innovative technology-driven growth companies across various sectors, including healthcare, information technology, SaaS, manufacturing, life sciences, oncology, big data, clean technology, and digital health. Capricorn Partners boasts a team of experienced investment managers with extensive technology expertise and broad industrial backgrounds, enabling them to identify and support promising European companies that leverage technology as a competitive advantage.

Jan Avonts

Investment Director

Damien van der Bijl

Investment Director

Daniela Arruda Costa

Investment Associate

Olaf Cörper

Partner

Paul Decraemer

Partner

Antoine D’Hollander

Investment Director

Katrin Geyskens

Partner

Steven Lambert

Investment Partner Digital

Maarten Lambert

Senior Associate

Marc Lambrechts

Investment Director

Steven Levecke

Partner

Rob van der Meij

Investment Manager

Jos B. Peeters

Founding Partner

Filip Pintelon

Investment Partner Health

Wouter Van de Putte

Investment Director

Daniel von Scheven

Investment Manager

Ekaterina Smirnyagina

Partner

Claude Stoufs

Partner

Leslie Totté

CFO

Yves Vaneerdewegh

Partner, Member of the Executive Committee and Board Member

Sabine Vermassen

Partner, Member of the Executive Committee and Board Member

Simon Wouters

Investment Analyst

89 past transactions

Chainels

Series A in 2023
CHAINels is a web based Business Platform providing a tailored communication and management tool for groups of SMEs. CHAINels offers an integral and low-cost solution to consolidate and facilitate communication between Business Interest group members, group management and the outside world. Using the most recent technology, CHAINels provides its customers with advanced tools to drastically increase the economic value of their Business Interest group. CHAINels platform is a fully web-based alternative to SAAS and Intranet custom made tools aimed at business interest groups. CHAINels aims to build a single environment offering both Intranet and Internet benefits to its users. The services are delivered through web-based platform for organizations, business groups, and companies where they can connect and interact with each other by establishing mutual links (chains). For business groups sharing the same interest, CHAINels offers tailored management, communication and identity maintenance solutions. For group members – the SMEs, the platform becomes a vessel of on line business presence, combining the functionality of a dynamic business directory with traits of a traditional business network.

Gradyent

Series A in 2022
Gradyent B.V. specializes in designing and developing cloud-based artificial intelligence software aimed at enhancing the management and optimization of district heating networks. Founded in 2019 and headquartered in Utrecht, the Netherlands, with a research and development center in The Hague, Gradyent's platform employs digital twin technology that integrates hydro and thermodynamic modeling with AI. This innovative approach allows for real-time optimization and forecasting of heating networks, while also enabling the detection of minor changes within the system. The platform provides district heating companies with a comprehensive overview of their network's current status and facilitates secure access to relevant information from any location at any time, promoting efficiency and responsiveness in energy management.

StoryChief

Venture Round in 2022
StoryChief.io is a content marketing software designed for startups, SEO marketers, and editorial teams seeking to streamline their content creation and distribution processes. The platform enables users to publish stories across multiple channels, including WordPress, Medium, newsletters, and various social media platforms, all from a single interface. Its universal editor allows for the easy creation of visually appealing articles tailored for different publishing formats. Additionally, StoryChief offers features such as SEO suggestions, performance tracking, and lead capture integration with CRM systems, helping users measure their impact and return on investment effectively. By centralizing content management, StoryChief enhances the reach and efficiency of content marketing efforts.

Finquest

Seed Round in 2022
Finquest is a platform specializing in mergers and acquisitions as well as direct investments, focusing on middle-market opportunities in Asia. Established in 2016 by Antoine Denaiffe, Tanguy Lesselin, Gerard Belicha, and Jerome Pinneau, Finquest utilizes a comprehensive database of 650,000 organizations and a proprietary algorithm to facilitate targeted introductions. The platform aims to streamline the process for clients seeking new investment opportunities by connecting them with relevant institutional investors and potential acquirers. Through its emphasis on big data and artificial intelligence, Finquest enhances the efficiency of mid-market deal-making by providing curated connections, ultimately supporting corporate buyers in their investment endeavors.

Zozio

Seed Round in 2022
Developer of a digital companion designed for industrial operators based on AI algorithms. The company's platform intends to change the way people work in the factory by creating Factory 4.0 and collecting, visualizing, and analyzing field data in real-time within the industrial site and outside making the factory more efficient, improving the working conditions of the operators and minimizing the waste of resources, enabling supply chain of manufacturers to improve their competitiveness on an international scale.

Black Bear Carbon

Venture Round in 2021
Black Bear Carbon BV specializes in converting waste tires into carbon black and green energy, operating primarily in the Netherlands and internationally. Founded in 2010 and based in Nederweert, the company utilizes a circular economy model to transform end-of-life tires into sustainable products. Its carbon black, a form of elemental carbon produced through controlled pyrolysis and partial combustion, is employed in various applications, including tires, technical rubber products, plastics, and paints. Additionally, Black Bear Carbon powers its tire shredding operations with electricity generated on-site, while also supplying excess energy to local industries and grids. By providing a renewable resource that reduces reliance on oil and lowers carbon dioxide emissions, the company promotes environmentally friendly practices in the manufacturing sector.

EclecticIQ

Series C in 2020
EclecticIQ B.V. is a global provider of threat intelligence, hunting, and response technology, supporting government organizations and commercial enterprises in enhancing their cybersecurity posture. Founded in 2014 and headquartered in Amsterdam, with additional offices in Herndon, Virginia; London, United Kingdom; and Chi?inau, Moldova, the company offers a range of products and services. These include the EclecticIQ Platform, a comprehensive threat intelligence platform; the EclecticIQ Fusion Center, which delivers multi-source threat intelligence bundles; and the EclecticIQ Academy for cyber threat intelligence training. The company also provides consulting services, team collaboration tools, and various integrations to optimize incident response and security controls. With a focus on building defenses against emerging threats, EclecticIQ has expanded its capabilities through acquisitions, such as Polylogyx's endpoint technology, to further enhance its offerings for clients facing sophisticated cyber threats.

Sensolus

Venture Round in 2020
Sensolus NV designs and develops global positioning system (GPS) trackers that allows to track non-powered assets. It offers turnkey solutions for wireless and low-power context-aware sensing. The company also provides a web based platform, Internet of things (IoT) cloud platform, and application that helps to provide real time information about assets. It serves manufacturing, waste management, cargo transport, transport and logistics, and automotive industry. The company was founded in 2013 and is based in Ghent, Belgium.

EclecticIQ

Series C in 2020
EclecticIQ B.V. is a global provider of threat intelligence, hunting, and response technology, supporting government organizations and commercial enterprises in enhancing their cybersecurity posture. Founded in 2014 and headquartered in Amsterdam, with additional offices in Herndon, Virginia; London, United Kingdom; and Chi?inau, Moldova, the company offers a range of products and services. These include the EclecticIQ Platform, a comprehensive threat intelligence platform; the EclecticIQ Fusion Center, which delivers multi-source threat intelligence bundles; and the EclecticIQ Academy for cyber threat intelligence training. The company also provides consulting services, team collaboration tools, and various integrations to optimize incident response and security controls. With a focus on building defenses against emerging threats, EclecticIQ has expanded its capabilities through acquisitions, such as Polylogyx's endpoint technology, to further enhance its offerings for clients facing sophisticated cyber threats.

Innovium

Series F in 2020
Innovium, Inc. develops and deploys switching silicon solutions for cloud, enterprise, and edge data centers in the United States and internationally. It offers TERALYNX 7 for large scale public and private cloud; and TERALYNX 5 for ToR, enterprise, Edge, and 5G data centers. The company also provides Network OS, a cloud, OEM, open-source network operating system; open source and standard APIs; and TERALYNX software development kit. Innovium, Inc. was incorporated in 2014 and is headquartered in San Jose, California with a location in Bengaluru, India.

Gradyent

Seed Round in 2020
Gradyent B.V. specializes in designing and developing cloud-based artificial intelligence software aimed at enhancing the management and optimization of district heating networks. Founded in 2019 and headquartered in Utrecht, the Netherlands, with a research and development center in The Hague, Gradyent's platform employs digital twin technology that integrates hydro and thermodynamic modeling with AI. This innovative approach allows for real-time optimization and forecasting of heating networks, while also enabling the detection of minor changes within the system. The platform provides district heating companies with a comprehensive overview of their network's current status and facilitates secure access to relevant information from any location at any time, promoting efficiency and responsiveness in energy management.

ViroVet

Series B in 2020
ViroVet NV develops virus control solutions for the livestock industry. It offers antiviral drugs for the control and treatment of respiratory diseases of cattle and swine. The company also offers modified live virus vaccines for endemic and epizootic viral livestock diseases. ViroVet NV was founded in 2015 and is based in Leuven, Belgium.

VOID Technologies

Venture Round in 2020
VOID Technologies Limited is a materials science company based in London, United Kingdom, with a manufacturing facility in Neenah, Wisconsin. Established in 2014, VOID Technologies specializes in the production and supply of VO+ additive masterbatches, which are utilized by film manufacturers across various applications, including labels, food packaging, bags, snacks, tapes, and strapping. The company emerged as a spin-out from Kimberly-Clark Corporation, aiming to commercialize the innovative VO+ technology. As a subsidiary of Kimberly-Clark, VOID Technologies is positioned to leverage its parent company's expertise while focusing on the advancement of sustainable materials in the packaging industry.

Prolupin

Venture Round in 2020
Prolupin GmbH is a spin-off from the Fraunhofer Institute for Process Engineering and Packaging IVV in Freising. The world-leading expertise on the fractionation of lupines and the application of this in food technology gives the business a strong position in the vegetable protein market. This position is secured by several Fraunhofer patents. The company's business activities focus on developing, producing and marketing vegetable-based, lactose-free milk substitutes from the blue sweet lupine (Lupinus angustifolius). This domestic legume is particularly rich in proteins, undemanding with regard to soil and climate and grows predominantly in Northern Germany (soybean of the north), Poland, Scandinavia, North America and Australia. With the processing technologies developed at Fraunhofer IVV, it is possible to adapt the lupine protein flavor profile in such a way as to achieve a milk-like taste.

DMC

Series A in 2019
DMC Biotechnologies, Inc. is a biotechnology company based in Boulder, Colorado, focused on developing bio-based products through microbial fermentation technology. The company specializes in the production of specialty chemicals, flavors, fragrances, nutraceuticals, and pharmaceuticals. By utilizing Dynamic Metabolic Control technology, DMC aims to streamline the production process, reducing both costs and development timelines from discovery to commercial viability. Founded in 2014, DMC Biotechnologies is dedicated to creating sustainable manufacturing solutions that utilize lower energy and resources, contributing to a more sustainable economy.

iSTAR Medical

Series C in 2019
iSTAR Medical SA is a Belgian company specializing in the development of innovative ophthalmic implants aimed at treating glaucoma. Founded in 2010 as a spinout of Healionics Corporation, the company has established a strong presence in the market with its flagship product, the STARflo glaucoma implant. This non-degradable, micro-porous drainage system reduces intraocular pressure in patients with open-angle glaucoma by enhancing the eye's natural uveoscleral outflow. iSTAR Medical also offers additional products, including STARflo PLUS and STARflo MINI, which provide surgical therapies for glaucoma. The implants are designed to integrate with surrounding tissue, exhibiting anti-fibrotic and anti-inflammatory properties, thereby minimizing complications and the need for medication. The company operates from its eco-friendly R&D and manufacturing facility in Belgium and distributes its products across various international markets, including Australia, China, France, Hungary, Italy, Poland, and Turkey. iSTAR Medical has received multiple quality certifications, including ISO 13485 and ISO 9001, and achieved CE Mark approval for its devices.

Arkite

Venture Round in 2019
Arkite NV manufactures automation products, Human Interface Mate, which assists the manufacturing operator by warning as soon as a wrong operation is in progress and navigates towards standardized work. The company was founded in 2015 and is based in Genk, Belgium.

icometrix

Series A in 2019
Icometrix is a company based in Leuven, Belgium, specializing in the development of automated MRI biomarkers for neurological disorders. Founded in 2011 as a spin-off from the universities and university hospitals of Leuven and Antwerp, the company provides standardized measurements of brain MRI scans to enhance personalized care for patients with conditions such as multiple sclerosis, dementia, and traumatic brain injury. Its key products include icobrain ms, which tracks disease progression in multiple sclerosis patients; cobrain dm, which quantifies brain structures in dementia patients; and icobrain tbi, which monitors axonal injuries in head trauma cases. Icometrix has gained international recognition for its solutions, which are widely used in clinical practice and research, including clinical trials for new drug development. The company is ISO certified for quality management and information security, and its software-as-a-service platform enables efficient processing of large volumes of brain imaging data, contributing to advancements in the understanding and treatment of neurological disorders.

Confo Therapeutics

Series A in 2019
Confo Therapeutics is a drug discovery company based in Brussels, Belgium, founded in 2015. The company specializes in developing internal drug discovery programs focused on G-protein coupled receptors (GPCRs) to address unmet medical needs. Utilizing its proprietary CONFO® technology, Confo Therapeutics stabilizes inherently unstable functional conformations of GPCRs, providing a robust starting point for drug discovery. This approach reveals previously inaccessible structural features of these receptors, facilitating the identification of novel agonists that enhance therapeutic interventions.

Miaa Guard

Venture Round in 2019
Miaa Guard CVBA, based in Leuven, Belgium, develops a cloud-based platform that provides access control solutions for digital businesses. The platform utilizes microservice APIs to manage access rights and policies tailored to both consumers and professionals within an enterprise context. It enables organizations to govern security and access, integrate data architecture, and customize configurations. Founded in 2009 and originally known as VintiQ, the company rebranded to Miaa Guard CVBA in 2014. Its services facilitate the monetization of digital assets while ensuring proper authorization among users.

Black Bear Carbon

Venture Round in 2018
Black Bear Carbon BV specializes in converting waste tires into carbon black and green energy, operating primarily in the Netherlands and internationally. Founded in 2010 and based in Nederweert, the company utilizes a circular economy model to transform end-of-life tires into sustainable products. Its carbon black, a form of elemental carbon produced through controlled pyrolysis and partial combustion, is employed in various applications, including tires, technical rubber products, plastics, and paints. Additionally, Black Bear Carbon powers its tire shredding operations with electricity generated on-site, while also supplying excess energy to local industries and grids. By providing a renewable resource that reduces reliance on oil and lowers carbon dioxide emissions, the company promotes environmentally friendly practices in the manufacturing sector.

c-LEcta

Venture Round in 2018
c-LEcta GmbH is a biotechnology company based in Leipzig, Germany, specializing in enzyme engineering and bioprocess development for regulated markets, including food and pharmaceuticals. Founded in 2004, the company focuses on creating application-oriented enzyme variants, which it either commercializes independently or develops in collaboration with industry partners. Among its notable products are DENARASE, a genetically engineered endonuclease designed for the removal of nucleic acids and viscosity reduction, and CalB Immo Plus, a hydrophobic immobilized CalB preparation. c-LEcta aims to provide customized enzymes and microbial strains through sustainable production processes, enabling clients to enhance their research and market capabilities.

Nexstim

Post in 2018
Nexstim Plc is a neuromodulation company based in Helsinki, Finland, that develops and markets non-invasive brain stimulation technologies. The company specializes in image-guided transcranial magnetic stimulation (TMS) through its proprietary SmartFocus technology, which features 3D navigation for both therapeutic and diagnostic purposes. Nexstim offers the NBT system, designed to treat major depressive disorder and chronic neuropathic pain, as well as the NBS system, which is utilized for pre-surgical mapping of the brain's speech and motor cortices. Primarily, the NBS systems are sold to universities and teaching hospitals. Founded in 2000, Nexstim aims to enhance the quality of life for patients with significant unmet clinical needs through its innovative approaches to brain therapy.

LindaCare

Series B in 2018
LindaCare LTD. is a Belgium-based company that specializes in developing a tele-monitoring dashboard for patients with chronic diseases, particularly those with cardiac implantable devices. The software integrates data from various device vendors and electronic patient records, enhancing workflow efficiency and reducing the risk of medical errors through customized alerts. By offering a vendor-independent platform, LindaCare aims to simplify the tele-monitoring process for healthcare professionals and hospitals, ultimately reducing the cost of care delivery while improving patient safety and the overall quality of care. This unified approach facilitates better tracking and monitoring of patient activities, benefiting both healthcare providers and family members involved in patient care management.

DMC

Seed Round in 2018
DMC Biotechnologies, Inc. is a biotechnology company based in Boulder, Colorado, focused on developing bio-based products through microbial fermentation technology. The company specializes in the production of specialty chemicals, flavors, fragrances, nutraceuticals, and pharmaceuticals. By utilizing Dynamic Metabolic Control technology, DMC aims to streamline the production process, reducing both costs and development timelines from discovery to commercial viability. Founded in 2014, DMC Biotechnologies is dedicated to creating sustainable manufacturing solutions that utilize lower energy and resources, contributing to a more sustainable economy.

NGDATA

Series C in 2017
NGDATA is a company that specializes in consumer intelligence management solutions, focusing on data-driven sectors such as retail, finance, media, and telecommunications. The company has developed Lily, a big data management system that extracts real-time business insights and enhances data utility. By combining big data management with machine learning technologies, NGDATA provides enterprises with a comprehensive platform to improve customer experience management. This platform delivers insights on both historical and real-time customer interactions, allowing organizations to engage with customers more effectively and drive customer loyalty. Headquartered in Ghent, Belgium, NGDATA also has offices in Singapore, Paris, New York City, and San Francisco.

Arkite

Venture Round in 2017
Arkite NV manufactures automation products, Human Interface Mate, which assists the manufacturing operator by warning as soon as a wrong operation is in progress and navigates towards standardized work. The company was founded in 2015 and is based in Genk, Belgium.

Sensolus

Seed Round in 2017
Sensolus NV designs and develops global positioning system (GPS) trackers that allows to track non-powered assets. It offers turnkey solutions for wireless and low-power context-aware sensing. The company also provides a web based platform, Internet of things (IoT) cloud platform, and application that helps to provide real time information about assets. It serves manufacturing, waste management, cargo transport, transport and logistics, and automotive industry. The company was founded in 2013 and is based in Ghent, Belgium.

ViroVet

Series A in 2017
ViroVet NV develops virus control solutions for the livestock industry. It offers antiviral drugs for the control and treatment of respiratory diseases of cattle and swine. The company also offers modified live virus vaccines for endemic and epizootic viral livestock diseases. ViroVet NV was founded in 2015 and is based in Leuven, Belgium.

FEops

Series B in 2017
FEops is a recognized pioneer in the field of physics-based simulations for minimally invasive cardiovascular devices and procedures. They apply this technology from bench to bed, by offering advice to medical device companies as well as to medical specialists and physicians. Their computer simulations have proven to provide medical device developers and manufacturers with unique insights, thereby speeding up R&D processes and supporting device safety. Physicians, for their part, benefit from new patient-specific insights that help them work more efficiently while, most importantly, improving patient safety.

NGDATA

Series B in 2017
NGDATA is a company that specializes in consumer intelligence management solutions, focusing on data-driven sectors such as retail, finance, media, and telecommunications. The company has developed Lily, a big data management system that extracts real-time business insights and enhances data utility. By combining big data management with machine learning technologies, NGDATA provides enterprises with a comprehensive platform to improve customer experience management. This platform delivers insights on both historical and real-time customer interactions, allowing organizations to engage with customers more effectively and drive customer loyalty. Headquartered in Ghent, Belgium, NGDATA also has offices in Singapore, Paris, New York City, and San Francisco.

Indigo Diabetes

Series A in 2016
Indigo Diabetes nv is a medical device company based in Ghent, Belgium, founded in 2016 by Danaë Delbeke and her team. The company specializes in developing an innovative invisible glucose monitor that utilizes advanced photonics technology to measure and manage blood glucose levels without the need for finger pricks. This high-tech sensor is designed to be inserted under the skin, allowing for continuous monitoring of blood sugar levels. Indigo Diabetes aims to enhance the user experience for individuals living with diabetes by providing a more accurate and convenient method for glucose monitoring, thereby transforming diabetes management.

Noona Healthcare

Seed Round in 2016
Noona Healthcare Oy is a Finnish company that specializes in a web-based mobile service aimed at improving the care of breast cancer patients. Founded in 2014 and based in Helsinki, its platform allows patients to report treatment-related symptoms directly to their healthcare providers via mobile devices, tablets, and computers. This real-time communication enhances the patient-clinic relationship, enabling clinical staff to respond quickly to severe symptoms and improve overall patient care. Additionally, Noona's platform assists researchers in developing new cancer therapies by generating valuable digital data that combines patient diagnosis, treatment, and genetic information. As of October 2018, Noona Healthcare operates as a subsidiary of Varian Medical Systems.

FRX Innovations

Series D in 2016
FRX Innovations Inc. is a manufacturer of environmentally sustainable flame retardant solutions, specializing in polyphosphonates under the brand name Nofia. The company produces a range of non-halogen, transparent, high melt flowing fire-resistant plastics that cater to various industries, including electronics, automotive, electric vehicles, medical devices, textiles, building and construction, and mass transit. FRX Innovations employs sustainable green chemistry principles in its production processes, utilizing solvent-free methods and generating no waste byproducts. Headquartered in Chelmsford, Massachusetts, with a manufacturing facility located in Antwerp, Belgium, the company distributes its products internationally through a network of distributors. Established in 2006, FRX Innovations operates as a subsidiary of Triton Systems, Inc.

Diagenode

Venture Round in 2016
Diagenode is an international life sciences company that develops and commercializes innovative instruments and reagents systems for life science research and molecular diagnostics. Founded in 2003 in Liege (Belgium), Diagenode is a global company, with headquarters in Liege, Belgium and Sparta, NJ, USA. Diagenode also has a local sales office in the United Kingdom to better serve this specific country. Diagenode's customers include leading epigenetics researchers, academic institutions, high-profile genome centers and core labs, life sciences tools companies, molecular diagnostics players, and pharmaceutical and biotechnology companies. Epigenetics Division

iSTAR Medical

Series B in 2016
iSTAR Medical SA is a Belgian company specializing in the development of innovative ophthalmic implants aimed at treating glaucoma. Founded in 2010 as a spinout of Healionics Corporation, the company has established a strong presence in the market with its flagship product, the STARflo glaucoma implant. This non-degradable, micro-porous drainage system reduces intraocular pressure in patients with open-angle glaucoma by enhancing the eye's natural uveoscleral outflow. iSTAR Medical also offers additional products, including STARflo PLUS and STARflo MINI, which provide surgical therapies for glaucoma. The implants are designed to integrate with surrounding tissue, exhibiting anti-fibrotic and anti-inflammatory properties, thereby minimizing complications and the need for medication. The company operates from its eco-friendly R&D and manufacturing facility in Belgium and distributes its products across various international markets, including Australia, China, France, Hungary, Italy, Poland, and Turkey. iSTAR Medical has received multiple quality certifications, including ISO 13485 and ISO 9001, and achieved CE Mark approval for its devices.

BlueBee

Series A in 2016
Bluebee Holding B.V., based in Rijswijk, the Netherlands, develops a cloud-based genomics analysis platform that accelerates the processing of sequencing data. Founded in 2011, the company provides solutions for research centers, sequencing service providers, clinical labs, and kit providers, enabling them to manage, process, and share large volumes of genomic data efficiently and affordably. The platform is designed to address the challenges posed by the rapid advancements in next-generation DNA sequencing technology, offering high-performance computing and clinical-grade security. By facilitating faster data processing and deep analytics, Bluebee aims to enhance the implementation of whole genome diagnostics in clinical settings, ultimately supporting the development of personalized treatments and innovative healthcare solutions. As of June 2020, Bluebee operates as a subsidiary of Illumina, Inc.

LindaCare

Series A in 2015
LindaCare LTD. is a Belgium-based company that specializes in developing a tele-monitoring dashboard for patients with chronic diseases, particularly those with cardiac implantable devices. The software integrates data from various device vendors and electronic patient records, enhancing workflow efficiency and reducing the risk of medical errors through customized alerts. By offering a vendor-independent platform, LindaCare aims to simplify the tele-monitoring process for healthcare professionals and hospitals, ultimately reducing the cost of care delivery while improving patient safety and the overall quality of care. This unified approach facilitates better tracking and monitoring of patient activities, benefiting both healthcare providers and family members involved in patient care management.

NGDATA

Series B in 2015
NGDATA is a company that specializes in consumer intelligence management solutions, focusing on data-driven sectors such as retail, finance, media, and telecommunications. The company has developed Lily, a big data management system that extracts real-time business insights and enhances data utility. By combining big data management with machine learning technologies, NGDATA provides enterprises with a comprehensive platform to improve customer experience management. This platform delivers insights on both historical and real-time customer interactions, allowing organizations to engage with customers more effectively and drive customer loyalty. Headquartered in Ghent, Belgium, NGDATA also has offices in Singapore, Paris, New York City, and San Francisco.

Sequana Medical

Series C in 2015
Sequana Medical is a medical device company based in Zurich, Switzerland, specializing in implantable pump systems designed to manage fluid balance in the body. The company's flagship product, the alfapump, addresses ascites, the accumulation of fluid in the abdominal cavity often associated with advanced liver disease, certain cancers, and congestive heart failure. The alfapump system facilitates the automatic and continuous removal of ascites by transferring excess fluid to the bladder, where it is expelled naturally. Additionally, Sequana Medical offers the alfapump DSR, which targets sodium removal in patients experiencing volume overload due to heart failure. Founded in 2006 and with a strong presence in Germany, Sequana Medical aims to improve the quality of life for patients suffering from fluid overload conditions through innovative treatment solutions.

Ogeda

Series B in 2015
Ogeda SA, a clinical-stage drug discovery company, invents and develops small molecule drugs targeting G-Protein Coupled Receptors. It offers fezolinetant (ESN364), a Phase II clinical development product for the treatment of women’s health disorders; NK3 antagonists for the treatment of hormone-dependent pathologies in women's health; and products for endocrine, CNS/inflammatory disorders. Ogeda SA was formerly known as Euroscreen SA and changed its name to Ogeda SA in October 2016. The company was founded in 1994 and is based in Gosselies, Belgium. It has a meeting facility in Brussels, Belgium; and an additional office in Paris, France. Ogeda SA operates as a subsidiary of Astellas Pharma Inc.

NovoPolymers

Venture Round in 2015
NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.

Green Biologics

Series C in 2015
Green Biologics Limited is an industrial biotechnology company based in Abingdon, United Kingdom, focused on producing renewable specialty chemicals. The company offers products such as n-butanol, acetone, and C4 derivatives, along with GreenFlame charcoal lighting fluids. These products find applications in various sectors, including paints, coatings, adhesives, personal care, cosmetics, food ingredients, health, and industrial cleaners. Green Biologics aims to be a leader in advanced fermentation technologies that convert biomass into renewable fuels and chemicals. Established in 2002, the company has additional facilities in the United States and satellite offices in China, Brazil, and India.

FEops

Series A in 2015
FEops is a recognized pioneer in the field of physics-based simulations for minimally invasive cardiovascular devices and procedures. They apply this technology from bench to bed, by offering advice to medical device companies as well as to medical specialists and physicians. Their computer simulations have proven to provide medical device developers and manufacturers with unique insights, thereby speeding up R&D processes and supporting device safety. Physicians, for their part, benefit from new patient-specific insights that help them work more efficiently while, most importantly, improving patient safety.

SpaceX

Series G in 2015
Space Exploration Technologies is a space-transportation startup company founded by Elon Musk. SpaceX designs, manufactures, and launches advanced rockets and spacecraft. SpaceX develops crew and cargo capsules, engines, cryogenic tank structures, avionics, equipment, guidance, and control software. The company is developing the partially reusable launch vehicles Falcon 1 and Falcon 9. Founded in 2002, Space Exploration Technologies is headquartered in Hawthorne, California.

Avantium

Series G in 2014
Avantium is a technology company based in Amsterdam, specializing in advanced high-throughput research and development for the energy, chemicals, and pharmaceutical sectors. It employs proprietary technology that accelerates and reduces the costs associated with developing new products and processes. Avantium's innovative approach to experiment design and data analysis enhances its success rate in delivering effective solutions. The company has successfully collaborated with over 70 global clients, showcasing the commercial viability of its services. Avantium focuses on two primary areas: developing biofuels and bio-based chemicals, as well as new crystal forms of patented drugs. Its business model includes a strong emphasis on expanding its patent portfolio and establishing partnerships that add value. Additionally, Avantium operates through segments such as R&D Solutions, Renewable Chemistries, and Renewable Polymers, with the R&D Solutions segment generating the majority of its revenue. The company is supported by a team of experts in various fields, including catalysis, organic chemistry, and software development, who work closely with partner organizations to drive innovation in sustainable chemistry.

Sequana Medical

Series C in 2014
Sequana Medical is a medical device company based in Zurich, Switzerland, specializing in implantable pump systems designed to manage fluid balance in the body. The company's flagship product, the alfapump, addresses ascites, the accumulation of fluid in the abdominal cavity often associated with advanced liver disease, certain cancers, and congestive heart failure. The alfapump system facilitates the automatic and continuous removal of ascites by transferring excess fluid to the bladder, where it is expelled naturally. Additionally, Sequana Medical offers the alfapump DSR, which targets sodium removal in patients experiencing volume overload due to heart failure. Founded in 2006 and with a strong presence in Germany, Sequana Medical aims to improve the quality of life for patients suffering from fluid overload conditions through innovative treatment solutions.

FRX Innovations

Series C in 2014
FRX Innovations Inc. is a manufacturer of environmentally sustainable flame retardant solutions, specializing in polyphosphonates under the brand name Nofia. The company produces a range of non-halogen, transparent, high melt flowing fire-resistant plastics that cater to various industries, including electronics, automotive, electric vehicles, medical devices, textiles, building and construction, and mass transit. FRX Innovations employs sustainable green chemistry principles in its production processes, utilizing solvent-free methods and generating no waste byproducts. Headquartered in Chelmsford, Massachusetts, with a manufacturing facility located in Antwerp, Belgium, the company distributes its products internationally through a network of distributors. Established in 2006, FRX Innovations operates as a subsidiary of Triton Systems, Inc.

Regalii

Seed Round in 2014
Arcus Financial Intelligence, Inc. operates a versatile application program interface (API) platform that supports banks and financial institutions in managing consumer bills and financial data. Founded in 2012 and based in New York, the company initially aimed to provide cross-border bill payment solutions under the name Regalii. However, it evolved to focus on domestic bill pay data, launching products like xData and xChange. Arcus offers real-time bill management and payment services, enabling users to gain insights into their financial obligations, including the number of bills, amounts owed, and due dates. The platform is widely used by notable fintech mobile payment applications, enhancing the accessibility and integration of financial services for consumers. Through its innovative fintech-as-a-service model, Arcus has raised significant investment from various venture capital firms and continues to drive advancements in payment solutions.

Green Biologics

Series B in 2013
Green Biologics Limited is an industrial biotechnology company based in Abingdon, United Kingdom, focused on producing renewable specialty chemicals. The company offers products such as n-butanol, acetone, and C4 derivatives, along with GreenFlame charcoal lighting fluids. These products find applications in various sectors, including paints, coatings, adhesives, personal care, cosmetics, food ingredients, health, and industrial cleaners. Green Biologics aims to be a leader in advanced fermentation technologies that convert biomass into renewable fuels and chemicals. Established in 2002, the company has additional facilities in the United States and satellite offices in China, Brazil, and India.

iSTAR Medical

Series A in 2013
iSTAR Medical SA is a Belgian company specializing in the development of innovative ophthalmic implants aimed at treating glaucoma. Founded in 2010 as a spinout of Healionics Corporation, the company has established a strong presence in the market with its flagship product, the STARflo glaucoma implant. This non-degradable, micro-porous drainage system reduces intraocular pressure in patients with open-angle glaucoma by enhancing the eye's natural uveoscleral outflow. iSTAR Medical also offers additional products, including STARflo PLUS and STARflo MINI, which provide surgical therapies for glaucoma. The implants are designed to integrate with surrounding tissue, exhibiting anti-fibrotic and anti-inflammatory properties, thereby minimizing complications and the need for medication. The company operates from its eco-friendly R&D and manufacturing facility in Belgium and distributes its products across various international markets, including Australia, China, France, Hungary, Italy, Poland, and Turkey. iSTAR Medical has received multiple quality certifications, including ISO 13485 and ISO 9001, and achieved CE Mark approval for its devices.

Trod Medical

Series B in 2013
Trod Medical S.A. is a medical equipment and surgical device manufacturer founded in 2006, with headquarters in Leuven, Belgium, and a presence in the Tampa Bay area, USA. The company specializes in developing innovative ablation technologies, particularly focusing on radiofrequency (RF) ablation devices. Trod Medical's flagship product, the EncageTM, is a disruptive percutaneous RF device that enables precise tissue ablation, significantly reducing collateral damage—a critical concern in treatments for conditions such as prostate cancer. With prostate cancer being one of the most prevalent cancers, affecting approximately 240,000 new patients annually in the United States, Trod Medical's technology addresses the limitations of conventional treatments that often lead to severe side effects, including erectile dysfunction and urinary incontinence. The company aims to enhance patient outcomes through its advanced medical devices designed for the focal ablation of soft tissues.

NGDATA

Series A in 2013
NGDATA is a company that specializes in consumer intelligence management solutions, focusing on data-driven sectors such as retail, finance, media, and telecommunications. The company has developed Lily, a big data management system that extracts real-time business insights and enhances data utility. By combining big data management with machine learning technologies, NGDATA provides enterprises with a comprehensive platform to improve customer experience management. This platform delivers insights on both historical and real-time customer interactions, allowing organizations to engage with customers more effectively and drive customer loyalty. Headquartered in Ghent, Belgium, NGDATA also has offices in Singapore, Paris, New York City, and San Francisco.

Green Biologics

Venture Round in 2013
Green Biologics Limited is an industrial biotechnology company based in Abingdon, United Kingdom, focused on producing renewable specialty chemicals. The company offers products such as n-butanol, acetone, and C4 derivatives, along with GreenFlame charcoal lighting fluids. These products find applications in various sectors, including paints, coatings, adhesives, personal care, cosmetics, food ingredients, health, and industrial cleaners. Green Biologics aims to be a leader in advanced fermentation technologies that convert biomass into renewable fuels and chemicals. Established in 2002, the company has additional facilities in the United States and satellite offices in China, Brazil, and India.

Mainstay Medical

Series B in 2012
Mainstay Medical Holdings plc is a medical device company based in Dublin, Ireland, with operations in the United States and Australia. Founded in 2008, the company specializes in developing and commercializing ReActiv8, an implantable neurostimulation system aimed at treating chronic low back pain. This innovative therapy is designed to restore control to the muscles that stabilize the lumbar spine, addressing a significant unmet need in the healthcare market. By collaborating with scientists and clinical experts, Mainstay Medical focuses on delivering effective solutions for patients suffering from debilitating pain, ultimately enhancing their quality of life.

Metallkraft

Acquisition in 2012
Metallkraft AS specializes in waste management and recycling, focusing on the processing and recovery of valuable materials from spent cutting fluid used in the production of silicon wafers for the solar and integrated circuitry industries. The company efficiently recycles silicon carbide, polyethylene glycol, and SiSiCar, a specific form of silicon carbide, by offering slurry recycling services. This enables organizations to enhance their production processes for silicon solar modules and optimize the cutting of silicon wafers, while also promoting sustainability in industrial practices.

Green Biologics

Venture Round in 2012
Green Biologics Limited is an industrial biotechnology company based in Abingdon, United Kingdom, focused on producing renewable specialty chemicals. The company offers products such as n-butanol, acetone, and C4 derivatives, along with GreenFlame charcoal lighting fluids. These products find applications in various sectors, including paints, coatings, adhesives, personal care, cosmetics, food ingredients, health, and industrial cleaners. Green Biologics aims to be a leader in advanced fermentation technologies that convert biomass into renewable fuels and chemicals. Established in 2002, the company has additional facilities in the United States and satellite offices in China, Brazil, and India.

Trinean

Venture Round in 2012
Trinean is a Belgium based technology provider, bringing micro-volume molecular spectroscopy to the next level by combining best in class analytical software with a highly standardized read-out platform. Founded in 2006 as a spin-out of the Ghent University, Belgium and Imec Leuven, Belgium, the company commercializes UV/VIS spectrometers for biomolecule quantification. The DropSense™16 and DropSense™96, analyzing up to 16 and 96 samples resp., use microfluidic chips for standardized sample analysis (DropPlates™ and Slides). The Trinean platform is complemented with a software toolbox for improved data interpretation and lab-automation.

NovoPolymers

Venture Round in 2012
NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.
Liquidity manufactures breakthrough water purification cartridges, based on revolutionary membrane nanoscience, to solve the world's potable water needs. Pour any non-salt water through their cartridge and drink it safely. It's that simple. No chemicals, no power nor pressure. Their product will save millions of lives currently lost to preventable waterborne diseases.

EpiGan

Venture Round in 2011
EpiGaN is a Leuven, Belgium-based company that specializes in the development of Gallium Nitride on Silicon (GaN) wafers. The company produces III-nitride epitaxial materials, primarily gallium nitride, which are known for their high power efficiency and reduced power losses. These materials are suited for a range of commercial applications, including AC drives, uninterruptible power supply (UPS) inverters, and hybrid and electric vehicles. EpiGaN's innovative technology aims to enhance performance and efficiency in various electronic systems.

FRX Innovations

Series B in 2011
FRX Innovations Inc. is a manufacturer of environmentally sustainable flame retardant solutions, specializing in polyphosphonates under the brand name Nofia. The company produces a range of non-halogen, transparent, high melt flowing fire-resistant plastics that cater to various industries, including electronics, automotive, electric vehicles, medical devices, textiles, building and construction, and mass transit. FRX Innovations employs sustainable green chemistry principles in its production processes, utilizing solvent-free methods and generating no waste byproducts. Headquartered in Chelmsford, Massachusetts, with a manufacturing facility located in Antwerp, Belgium, the company distributes its products internationally through a network of distributors. Established in 2006, FRX Innovations operates as a subsidiary of Triton Systems, Inc.

Nexstim

Venture Round in 2011
Nexstim Plc is a neuromodulation company based in Helsinki, Finland, that develops and markets non-invasive brain stimulation technologies. The company specializes in image-guided transcranial magnetic stimulation (TMS) through its proprietary SmartFocus technology, which features 3D navigation for both therapeutic and diagnostic purposes. Nexstim offers the NBT system, designed to treat major depressive disorder and chronic neuropathic pain, as well as the NBS system, which is utilized for pre-surgical mapping of the brain's speech and motor cortices. Primarily, the NBS systems are sold to universities and teaching hospitals. Founded in 2000, Nexstim aims to enhance the quality of life for patients with significant unmet clinical needs through its innovative approaches to brain therapy.

Sequana Medical

Series B in 2011
Sequana Medical is a medical device company based in Zurich, Switzerland, specializing in implantable pump systems designed to manage fluid balance in the body. The company's flagship product, the alfapump, addresses ascites, the accumulation of fluid in the abdominal cavity often associated with advanced liver disease, certain cancers, and congestive heart failure. The alfapump system facilitates the automatic and continuous removal of ascites by transferring excess fluid to the bladder, where it is expelled naturally. Additionally, Sequana Medical offers the alfapump DSR, which targets sodium removal in patients experiencing volume overload due to heart failure. Founded in 2006 and with a strong presence in Germany, Sequana Medical aims to improve the quality of life for patients suffering from fluid overload conditions through innovative treatment solutions.

NovoPolymers

Series B in 2011
NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.

Ensartech

Venture Round in 2011
Ensartech is engages in mastering high temperature processes to process highly polluted waste and residual streams of various industries and convert them into various types of energy.

Ducatt

Venture Round in 2010
Ducatt NV is a Belgium-based start-up specializing in the manufacturing of solar glasses designed to enhance the efficiency of solar systems. The company offers ultra-clear patterned glasses available in various thicknesses, allowing clients to choose products that meet their specific needs while ensuring affordability. By focusing on innovative glass solutions for the solar industry, Ducatt aims to contribute to the advancement of renewable energy technologies.

Green Biologics

Series B in 2010
Green Biologics Limited is an industrial biotechnology company based in Abingdon, United Kingdom, focused on producing renewable specialty chemicals. The company offers products such as n-butanol, acetone, and C4 derivatives, along with GreenFlame charcoal lighting fluids. These products find applications in various sectors, including paints, coatings, adhesives, personal care, cosmetics, food ingredients, health, and industrial cleaners. Green Biologics aims to be a leader in advanced fermentation technologies that convert biomass into renewable fuels and chemicals. Established in 2002, the company has additional facilities in the United States and satellite offices in China, Brazil, and India.

Anteryon

Venture Round in 2010
Anteryon B.V. designs and manufactures high-tech optical solutions. It offers micro-optics solutions, such as camera modules, stacked wafers, and lens wafers; lenses, including aspheric lenses, lens arrays, free form lenses, and lenticulars; lasers that comprise diode laser modules, fiber collimators, and assemblies; and planar optics, which include substrates, precision optics, optical coatings, and powder blasting. The company serves semiconductor lithography, measurement equipment, data storage, and optical media markets. Anteryon B.V. was formerly known as Philips Optics and changed its name to Anteryon B.V. in 2006. The company was founded in 1943 and is based in Eindhoven, the Netherlands. Anteryon B.V. operates as a subsidiary of Anteryon International B.V.

FRX Innovations

Series A in 2009
FRX Innovations Inc. is a manufacturer of environmentally sustainable flame retardant solutions, specializing in polyphosphonates under the brand name Nofia. The company produces a range of non-halogen, transparent, high melt flowing fire-resistant plastics that cater to various industries, including electronics, automotive, electric vehicles, medical devices, textiles, building and construction, and mass transit. FRX Innovations employs sustainable green chemistry principles in its production processes, utilizing solvent-free methods and generating no waste byproducts. Headquartered in Chelmsford, Massachusetts, with a manufacturing facility located in Antwerp, Belgium, the company distributes its products internationally through a network of distributors. Established in 2006, FRX Innovations operates as a subsidiary of Triton Systems, Inc.

NovoPolymers

Series A in 2009
NovoPolymers NV develops encapsulant solutions for the photovoltaic market. It offers thermoplastic encapsulant sheets for crystalline silicon based photovoltaic modules; and hydrocarbon thermoplastic elastomer materials. The company was founded in 2008 and is based in Puurs, Belgium.

Neosens

Series B in 2009
Neosens SA specializes in the design and development of sensor technologies aimed at monitoring and controlling water and industrial liquids. Founded in 2001 and headquartered in Labege, France, the company offers solutions that detect dissolved oxygen levels and monitor fouling in various liquid environments. Its sensor systems find applications in a range of industries, including cooling systems, heat exchangers, potable water treatment, ultra-pure water production, and industrial boilers. Additionally, Neosens' technology is utilized in sectors such as food and beverage, pharmaceuticals, pulp and paper, oil, gas, and petrochemicals. The company's innovative approach leverages microelectronic sensors to ensure the quality and integrity of liquid processes in diverse environments.

Metallkraft

Series A in 2008
Metallkraft AS specializes in waste management and recycling, focusing on the processing and recovery of valuable materials from spent cutting fluid used in the production of silicon wafers for the solar and integrated circuitry industries. The company efficiently recycles silicon carbide, polyethylene glycol, and SiSiCar, a specific form of silicon carbide, by offering slurry recycling services. This enables organizations to enhance their production processes for silicon solar modules and optimize the cutting of silicon wafers, while also promoting sustainability in industrial practices.

Avantium

Venture Round in 2008
Avantium is a technology company based in Amsterdam, specializing in advanced high-throughput research and development for the energy, chemicals, and pharmaceutical sectors. It employs proprietary technology that accelerates and reduces the costs associated with developing new products and processes. Avantium's innovative approach to experiment design and data analysis enhances its success rate in delivering effective solutions. The company has successfully collaborated with over 70 global clients, showcasing the commercial viability of its services. Avantium focuses on two primary areas: developing biofuels and bio-based chemicals, as well as new crystal forms of patented drugs. Its business model includes a strong emphasis on expanding its patent portfolio and establishing partnerships that add value. Additionally, Avantium operates through segments such as R&D Solutions, Renewable Chemistries, and Renewable Polymers, with the R&D Solutions segment generating the majority of its revenue. The company is supported by a team of experts in various fields, including catalysis, organic chemistry, and software development, who work closely with partner organizations to drive innovation in sustainable chemistry.

Fluxome

Series B in 2008
Fluxome is a global supplier of natural ingredients aimed at enhancing human health and wellness. The company specializes in producing nutraceutical ingredients, notably pure resveratrol, derived from renewable sources through innovative technology. Fluxome's commitment to developing safe and natural health products distinguishes it in the market, as it seeks to provide effective solutions that can positively impact its customers' well-being.

Ensartech

Venture Round in 2008
Ensartech is engages in mastering high temperature processes to process highly polluted waste and residual streams of various industries and convert them into various types of energy.

CoreOptics

Venture Round in 2008
CoreOptics specializes in providing advanced solutions for high-speed optical networking applications within the telecommunications and information technology sectors. The company is recognized for its 10G and 40G Distortion Tolerant Transponder Modules and integrated circuit solutions, which are essential for Metro, Regional, and Long Haul optical and data networks. CoreOptics advocates for open optical communication systems that can efficiently transmit data across various rates and fiber types. Its innovative maximum likelihood sequence estimation (MLSE)-based equalization technology is notable for enabling Tier 1 systems vendors and carriers to enhance network performance without overhauling existing fiber infrastructure. By eliminating the need for Optical Compensators and Second Stage Amplifiers, CoreOptics' products can significantly lower first-in deployment costs for customers, achieving reductions of up to 30%.

iNEWiT

Venture Round in 2008
iNEWiT is an engineering company based in Mechelen, Belgium, founded in 2005. The company specializes in identifying, designing, and creating applications and devices for the mobile market. It develops mobile video communication applications and offers a range of wireless communication technologies, including GPRS/EDGE, 3G, HSDPA/HSUPA, WiFi, WiMAX, and satellite networks. iNEWiT's products utilize patent-pending technology to transmit data, video, and sound across various wireless and wired environments and platforms. Additionally, the company provides plug-and-play products tailored for the business-to-consumer markets.

Neosens

Venture Round in 2008
Neosens SA specializes in the design and development of sensor technologies aimed at monitoring and controlling water and industrial liquids. Founded in 2001 and headquartered in Labege, France, the company offers solutions that detect dissolved oxygen levels and monitor fouling in various liquid environments. Its sensor systems find applications in a range of industries, including cooling systems, heat exchangers, potable water treatment, ultra-pure water production, and industrial boilers. Additionally, Neosens' technology is utilized in sectors such as food and beverage, pharmaceuticals, pulp and paper, oil, gas, and petrochemicals. The company's innovative approach leverages microelectronic sensors to ensure the quality and integrity of liquid processes in diverse environments.

Certess

Venture Round in 2007
Certess is an electronic design automation (EDA) company that specializes in functional qualification products aimed at businesses developing and integrating complex design blocks or intellectual property (IP). The company's software addresses the challenges faced by advanced functional verification teams, who often struggle to achieve true verification quality despite using various techniques. Certess provides tools that enable design and verification engineers to objectively evaluate and enhance the completeness of their verification environments, which helps reduce functional logic errors—key contributors to chip respins. By streamlining the integration process of System-on-Chip (SoC) designs, Certess ensures higher quality outcomes. Founded in 2005 and based in Campbell, California, Certess was acquired by SpringSoft, LLC in March 2009.

Mendel

Series D in 2007
Mendel Biotechnology, Inc. is a plant biotechnology company based in Hayward, California, focused on developing genetic and chemical solutions for various agricultural markets. Founded in 1997, the company specializes in enhancing agricultural productivity through innovations in biofuel feedstocks, yield enhancement, drought and freezing tolerance, disease resistance, nutrient use efficiency, and cold germination. Mendel has established strategic partnerships with notable organizations in the industry, including Monsanto Corporation, BP, and Bayer CropScience. Its operations extend across the United States, Europe, and China, reflecting a commitment to advancing agricultural technology and sustainability.

MAPPER Lithography

Series B in 2007
MAPPER Lithography B.V. specializes in developing maskless lithography infrastructure for the semiconductor industry. Founded in 2000 and headquartered in Delft, the Netherlands, the company designs and manufactures tools that utilize multiple electron-beam technology for semiconductor production. This innovative approach enables the fabrication of chips without the need for traditional masks, streamlining the manufacturing process. MAPPER Lithography also operates a manufacturing facility in Moscow, Russia, further supporting its capabilities in the semiconductor sector.

Clear2Pay

Series D in 2006
Clear2Pay is a payments technology company that specializes in providing innovative solutions for secure and efficient payment processing. Its key offering, the Open Payment Framework (OPF), allows financial institutions to enhance their internal payment processing while delivering improved services to clients, characterized by speed and detailed payment information. The OPF employs a centralized payments engine supported by a library of reusable business services, enabling banks to integrate new service models with their existing infrastructures. This approach helps institutions modernize their payment systems while safeguarding previous investments. Additionally, Clear2Pay offers a Software Development Kit and a Bank Payment Hub, which facilitate customer interaction, order management, and payment execution, along with services for dispute and exception processing.

Gemidis

Series C in 2006
Gemidis is a spin-off company from Ghent University (Belgium) and IMEC (Belgium) and was officially founded in August 2004. Gemidis develops, produces and sells LCOS imagers and driver electronics for both consumer and professional markets.

Welcome Real-time

Venture Round in 2005
Welcome Real-time S.A. provides credit and debit card acceptance, and payment integrated value-added service solutions for the banks, retailers, merchants, and financial organizations. Its products include XLS Server, which adds EMV capabilities to a bank's payment authorization and processing system; XLS POS that includes software libraries used by POS developers to create full featured payment applications; XLS Card, which includes personalization specifications and card applets used to add payment parameters and data next to EMV risk parameters, and data during the card issuance process; CardCare that provides card activity reporting and card's contents to facilitate cardholder services, such as card replacements and cardholder inquiries through a bank's Website or call centre; and MerchantCare, which provides a bank's merchant services with merchant activity reporting, as well as a view of merchant's transaction activity and payment parameter settings. The company was founded in 1996 and is headquartered in Aix-en-Province, France with additional offices, and research and development facilities in Singapore, Singapore; Madrid, Spain; Miami, Florida; Shanghai, China; and Sao Paulo, Brazil.

TiGenix

Venture Round in 2003
TiGenix NV (TiGenix) and its subsidiaries TiGenix Inc. and TC CEF LLC. is a Belgium-based biomedical company that focuses on innovative local treatments for damaged and osteoarthritic joints. The Company is exploiting the power of regenerative medicine for the development of durable treatments, validated through controlled clinical studies, for these indications. TiGenix is located in Leuven and was founded as a spin-off of the Catholic University of Leuven and the University of Ghent. TiGenix is developing a portfolio of products that addresses specific musculoskeletal problems. The lead indication among these is cartilage damage, which is a debilitating affliction severely affecting the mobility and functioning of patients. During the fiscal year ended December 31, 2009, the Company acquired Orthomimetics Ltd.

Curl

Series D in 2002
Curl is a technology company based in Cambridge, Massachusetts, that specializes in developing the Curl Rich Internet Application (RIA) platform. Established in 2002, the company emerged from research conducted at the Massachusetts Institute of Technology. Curl's platform enables the creation of complex, business-critical web applications that leverage local processing and offline capabilities while maintaining a secure environment. This hybrid approach, known as "fit clients," combines the benefits of Thick Clients and Thin Clients, allowing developers to handle large datasets and implement sophisticated data input and visualization features. Curl's technology is particularly suited for enterprises requiring robust solutions for mission-critical applications, including those with demanding graphical rendering needs. The company has served notable clients such as Nissan, Panasonic, and Mitsubishi, and continues to enhance its offerings, with recent updates aimed at improving accessibility for desktop users.

Equator Technologies

Series D in 2000
Equator Technologies, Inc. is a provider of system-on-a-chip processors for video streaming and image processing applications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.